CUE BIOPHARMA INC. -
1.7800
07-November-24 15:59:28
15 minutes delayed
Stocks
+0.1300
+7.88%
Today's range
1.5900 - 1.9000
ISIN
N/A
Source
NASDAQ
-
Cue Biopharma Reports First Quarter 2022 Financial Results
10 May 2022 16:30:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Upcoming Oppenheimer 32nd Annual Healthcare Conference
10 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
02 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
15 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast for Ongoing CUE-101 Clinical Trials
20 Jan 2022 08:00:01 By Nasdaq GlobeNewswire
-
05 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces Appointment of Patricia Nasshorn as Chief Business Officer
15 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at JMP Securities Hematology and Oncology Summit
06 Dec 2021 08:00:03 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference
22 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
10 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
21 Oct 2021 12:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
28 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
21 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
09 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
17 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
10 Aug 2021 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference
03 Aug 2021 08:01:12 By Nasdaq GlobeNewswire